Pluribus season one has ended. As the wait for season two of the Apple TV series begins, newly minted fans of lead actor Rhea ...

Bluespring Wealth Partners, a unit of Kestra Holdings, is closing out the year with more than $6 billion in new assets obtained through acquisitions. The end of 2025 also marks the first full year of ...

Kestra Medical Technologies (KMTS) has pulled back over the past week and month, even after a strong run in the past 3 months. This makes the recent move worth unpacking. See our latest analysis for ...

Wearable medical device and digital healthcare company Kestra Medical Technologies (KMTS) priced its upsized underwritten public offering of 6M common shares at a price to the public of $23.00 per ...

Brian Webster, President and CEO, highlighted strong financial performance in Q2, noting "revenue was $22.6 million with growth of 53% over the prior year period." He emphasized the milestone of ...

Revenue: $22.6 million, a 53% increase over the prior year period. Gross Margin: 50.6%, up from 39.6% in the prior year period. Operating Expenses: $43.2 million, including $1 million of non-recurring ...

Bluespring Wealth Partners, the registered investment advisor acquisition arm of Kestra Holdings, brought on an annual record of $6 billion in client assets via acquisition in 2025 through a mix of ...

Piper Sandler responded by raising its price target for Kestra to $30 from $27, while maintaining an Overweight rating on the stock. This adjustment came after Kestra’s fiscal second-quarter results, ...

After raising more than twice as much as expected in its March IPO, Kestra Medical Technologies Inc. appears poised to repeat its success with an upsized secondary offering as well. The Kirkland, Wash ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) Q2 2026 Earnings Call Transcript December 11, 2025 KESTRA MEDICAL TECHNOLOGIES, LTD. misses on earnings expectations. Reported EPS is $-0.62 EPS, ...

Kestra Medical Technologies (KMTS) reported its Q2 2025 earnings, revealing a robust revenue growth of 53% year-over-year, reaching $22.6 million. Despite this impressive growth, the company posted a ...